✦ LIBER ✦

Latanoprost Systemic Exposure in Pediatric and Adult Patients with Glaucoma: A Phase 1, Open-Label Study

✍ Scribed by Susan Raber; Rachel Courtney; Tomoko Maeda-Chubachi; Brad D. Simons; Sharon F. Freedman; Barbara Wirostko

Book ID: 116806209
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 356 KB
Volume: 118
Category: Article
ISSN: 0161-6420
DOI: 10.1016/j.ophtha.2011.03.039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line therapy with latanoprost 0.00

First-line therapy with latanoprost 0.005% results in improved ocular circulation in newly diagnosed primary open-angle glaucoma patients: a prospective, 6-month, open-label study

✍ Gherghel, D; Hosking, S L; Cunliffe, I A; Armstrong, R A 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 150 KB

Comparison of latanoprost with fixed-com

Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: An eight-week, randomized, open-label, parallel-group, multicenter study in Latin America

✍ Remo Sussana Jr; Wang-Pui Sheu; Latin American Glaucoma Society 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 141 KB

A randomized double-masked crossover stu

A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension

✍ Tin Aung; Paul T.K Chew; Chee-Chew Yip; Yiong-Huak Chan; Jovina L.S See; Christo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Rituximab treatment in patients with pri

Rituximab treatment in patients with primary Sjögren's syndrome: An open-label phase II study

✍ J. Pijpe; G. W. van Imhoff; F. K. L. Spijkervet; J. L. N. Roodenburg; G. J. Wolb 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 2 views

Mitomycin-C-augmented deep sclerectomy i

Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study

✍ Minna Ollikainen; Tuomo Puustjärvi; Petri Rekonen; Hannu Uusitalo; Markku Teräsv 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 214 KB

A phase II, multicenter, open-label stud

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features

✍ Nicolino Ruperto; Pierre Quartier; Nico Wulffraat; Patricia Woo; Angelo Ravelli; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 2 views